Sekisui Chemical Co., Ltd. (FRA:SUI)
Germany · Delayed Price · Currency is EUR 14.40
-0.30 (-2.04%)
Last updated: Jan 29, 2026, 8:16 AM CET
Sekisui Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 1,302,319 | 1,297,754 | 1,256,538 | 1,242,521 | 1,157,945 | 1,056,560 | |
Revenue Growth (YoY) | 1.12% | 3.28% | 1.13% | 7.30% | 9.60% | -6.44% |
Cost of Revenue | 880,945 | 877,147 | 864,343 | 865,281 | 801,994 | 726,174 |
Gross Profit | 421,374 | 420,607 | 392,195 | 377,240 | 355,951 | 330,386 |
Selling, General & Admin | 256,998 | 251,775 | 239,679 | 230,198 | 215,806 | 213,139 |
Research & Development | 44,249 | 44,249 | 41,701 | 40,471 | 37,010 | 35,110 |
Operating Expenses | 317,878 | 312,655 | 297,795 | 285,574 | 267,071 | 263,084 |
Operating Income | 103,496 | 107,952 | 94,400 | 91,666 | 88,880 | 67,302 |
Interest Expense | -1,279 | -1,038 | -1,103 | -871 | -774 | -861 |
Interest & Investment Income | 5,587 | 5,394 | 5,457 | 4,888 | 4,357 | 4,852 |
Earnings From Equity Investments | -1,137 | -1,092 | 843 | 2,254 | 108 | 2,753 |
Currency Exchange Gain (Loss) | -1,202 | -411 | 6,958 | 5,195 | 4,816 | 543 |
Other Non Operating Income (Expenses) | 2,052 | 2,079 | -210 | 1,815 | -387 | -11,940 |
EBT Excluding Unusual Items | 107,517 | 112,884 | 106,345 | 104,947 | 97,000 | 62,649 |
Gain (Loss) on Sale of Investments | 4,609 | 14,055 | 11,458 | -130 | 25,909 | 1,530 |
Gain (Loss) on Sale of Assets | -2,629 | -2,251 | -1,773 | -2,174 | -1,544 | 1,428 |
Asset Writedown | -22,282 | -4,714 | -4,554 | -3,148 | -51,508 | -2,428 |
Other Unusual Items | -1 | -1 | 1 | -2 | - | - |
Pretax Income | 87,214 | 119,973 | 111,477 | 99,493 | 69,857 | 63,179 |
Income Tax Expense | 23,760 | 35,867 | 32,424 | 28,726 | 31,098 | 19,902 |
Earnings From Continuing Operations | 63,454 | 84,106 | 79,053 | 70,767 | 38,759 | 43,277 |
Minority Interest in Earnings | -2,193 | -2,181 | -1,123 | -1,504 | -1,692 | -1,733 |
Net Income | 61,261 | 81,925 | 77,930 | 69,263 | 37,067 | 41,544 |
Net Income to Common | 61,261 | 81,925 | 77,930 | 69,263 | 37,067 | 41,544 |
Net Income Growth | -30.38% | 5.13% | 12.51% | 86.86% | -10.78% | -29.50% |
Shares Outstanding (Basic) | 407 | 418 | 425 | 435 | 446 | 452 |
Shares Outstanding (Diluted) | 407 | 418 | 425 | 435 | 446 | 452 |
Shares Change (YoY) | -2.78% | -1.55% | -2.38% | -2.38% | -1.39% | -1.66% |
EPS (Basic) | 147.73 | 195.93 | 183.48 | 159.19 | 83.17 | 91.92 |
EPS (Diluted) | 147.73 | 195.93 | 183.48 | 159.19 | 83.17 | 91.92 |
EPS Growth | -29.64% | 6.78% | 15.26% | 91.41% | -9.52% | -28.32% |
Free Cash Flow | 13,206 | 61,127 | 60,562 | 26,869 | 68,026 | 19,912 |
Free Cash Flow Per Share | 32.41 | 146.19 | 142.59 | 61.75 | 152.63 | 44.06 |
Dividend Per Share | 82.000 | 79.000 | 74.000 | 59.000 | 49.000 | 47.000 |
Dividend Growth | 7.90% | 6.76% | 25.42% | 20.41% | 4.25% | 2.17% |
Gross Margin | - | 32.41% | 31.21% | 30.36% | 30.74% | 31.27% |
Operating Margin | 7.95% | 8.32% | 7.51% | 7.38% | 7.68% | 6.37% |
Profit Margin | 4.70% | 6.31% | 6.20% | 5.57% | 3.20% | 3.93% |
Free Cash Flow Margin | 1.01% | 4.71% | 4.82% | 2.16% | 5.88% | 1.88% |
EBITDA | 160,285 | 161,708 | 147,072 | 144,072 | 137,584 | 116,647 |
EBITDA Margin | - | 12.46% | 11.71% | 11.59% | 11.88% | 11.04% |
D&A For EBITDA | 56,789 | 53,756 | 52,672 | 52,406 | 48,704 | 49,345 |
EBIT | 103,496 | 107,952 | 94,400 | 91,666 | 88,880 | 67,302 |
EBIT Margin | - | 8.32% | 7.51% | 7.38% | 7.68% | 6.37% |
Effective Tax Rate | - | 29.90% | 29.09% | 28.87% | 44.52% | 31.50% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.